ArticlePediatric blood & cancer2019

No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapy.

Katherine M Robinson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.